The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...

Credit: Shutterstock. Nalmefene HCl is an alternative to naloxone to reverse the effects of opioids, including respiratory depression, sedation, and hypotension. The Food and Drug Administration (FDA) ...

Review the side-effects of Nalmefene as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Nalmefene has a significant potential for helping individuals with alcohol dependence in reducing their alcohol consumption and allowing individuals to be in control of their alcohol intake The ...

“Nalmefene, an opioid antagonist, was recently approved by the European Medicines Agency for the treatment of alcohol dependence in order to help reduce alcohol consumption in adults who consume more ...

Purdue Pharma has obtained the Food and Drug Administration’s clearance for nalmefene hydrochloride injection, 2mg/2mL (1mg/1mL). Nalmefene is an opioid antagonist indicated for the complete or ...

In response to the recent approval of nalmefene nasal spray by the US Food and Drug Administration (FDA) for the emergency treatment of opioid overdose, a consortium of experts in pharmacology, ...

The Nalmefene market presents growth opportunities in global regions through diverse applications, supported by manufacturing innovations and patent analysis. Trends and demand dynamics from 2019 to ...

Pharmacodynamic studies have shown that nalmefene has a longer duration of action than naloxone. Nalmefene Hydrochloride Injection is now available for the complete or partial reversal of opioid drug ...

Please provide your email address to receive an email when new articles are posted on . Nalmefene can reduce the effects of opioid overdoses, like low BP, when administered quickly. Zurnai was ...